Qiagen N.V. 6-K Filing
Ticker: QGEN · Form: 6-K · Filed: Dec 22, 2025 · CIK: 1015820
| Field | Detail |
|---|---|
| Company | Qiagen N.V. (QGEN) |
| Form Type | 6-K |
| Filed Date | Dec 22, 2025 |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Qiagen N.V. (ticker: QGEN) to the SEC on Dec 22, 2025.
How long is this filing?
Qiagen N.V.'s 6-K filing is 1 pages with approximately 211 words. Estimated reading time is 1 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 211 words · 1 min read · ~1 pages · Grade level 8.8 · Accepted 2025-12-19 18:51:08
Filing Documents
- a12182025ssbb6-k.htm (6-K) — 18KB
- exhibit991announcementssbb.htm (EX-99.1) — 22KB
- image.jpg (GRAPHIC) — 10KB
- qiagen_logo.jpg (GRAPHIC) — 68KB
- 0001015820-25-000077.txt ( ) — 149KB
Signatures
Signatures 4 Exhibit Index 5 2 Other Information On December 18, 2025, QIAGEN N.V. (NYSE QGEN Frankfurt Prime Standard QIA) issued a press release with details for completion of a synthetic share repurchase plan that combines a direct capital repayment with a reverse stock split. The press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein. 3
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. QIAGEN N.V. By s Roland Sackers Roland Sackers Chief Financial Officer Date December 19, 2025 4 Exhibit Index Exhibit No. Exhibit 99.1 Press Release dated December 18, 2025 5